VanEck Associates’s Uranium Royalty Corp UROY Stock Holding History

VanEck Associates’s Portfolio UROY Stock Details UROY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.59M	Buy	+392,375	New	+$1.47M	﹤0.01%	1074

Other funds holding UROY

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Sprott Inc Toronto, Ontario, Canada $3.3B AUM 27.97% 1-Year Est. Return

Simcoe Capital Spokane, Washington $146M AUM 53.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return

VanEck Associates's UROY Position: Q3 2026 in Review

VanEck Associates opened a new position in Uranium Royalty Corp (UROY) in Q3 2026: 392,375 shares worth $1.59M. The stake represents ﹤0.01% of the portfolio and ranks #1074 among its holdings.

82 funds tracked by Wall St. Rank hold UROY as of Q3 2026.

VanEck Associates held 392,375 shares of Uranium Royalty Corp worth $1.59M as of Q3 2026.
Uranium Royalty Corp was a new VanEck Associates position in Q3 2026.
Uranium Royalty Corp made up ﹤0.01% of VanEck Associates's portfolio in Q3 2026, its #1074 holding.
82 funds tracked by Wall St. Rank held Uranium Royalty Corp as of Q3 2026.

Based on VanEck Associates's 13F filing for Q3 2026, filed 13 Nov 2026.